Get the Stockscreener App
7.43
5.23%
-0.41
Astria Therapeutics Inc stock is traded at $7.43, with a volume of 291.94K.
It is down -5.23% in the last 24 hours and up +11.73% over the past month.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
See More
Previous Close:
$7.84
Open:
$7.86
24h Volume:
291.94K
Relative Volume:
0.98
Market Cap:
$419.31M
Revenue:
-
Net Income/Loss:
$-72.89M
P/E Ratio:
-3.0702
EPS:
-2.42
Net Cash Flow:
$-68.47M
1W Performance:
-1.20%
1M Performance:
+11.73%
6M Performance:
+4.06%
1Y Performance:
-30.04%
1-Day Range:
$7.42
$7.935
1-Week Range:
$7.12
$7.935
52-Week Range:
$3.555
$12.92
Astria Therapeutics Inc Stock (ATXS) Company Profile
Name
Astria Therapeutics Inc
Sector
Industry
Phone
617-349-1971
Address
22 BOSTON WHARF ROAD, BOSTON
Compare ATXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
7.43 | 422.70M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-31-25 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | TD Cowen | Buy |
| Mar-28-23 | Initiated | Evercore ISI | Outperform |
Astria Therapeutics Inc Stock (ATXS) Latest News
Adage Capital Partners GP L.L.C. Reduces Stock Position in Astria Therapeutics, Inc. $ATXS - MarketBeat
Applying Elliott Wave Theory to Astria Therapeutics Inc.July 2025 Price Swings & High Return Trade Guides - Newser
Using data filters to optimize entry into Astria Therapeutics Inc.Trend Reversal & Reliable Entry Point Alerts - Newser
What does recent volatility data suggest for Astria Therapeutics Inc.Weekly Stock Report & Safe Swing Trade Setups - Newser
How hedge fund analytics apply to Astria Therapeutics Inc. stock2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser
What to expect from Astria Therapeutics Inc. in the next 30 daysWeekly Trade Review & Step-by-Step Trade Execution Guides - Newser
Can a trend reversal in Astria Therapeutics Inc. lead to recoveryJuly 2025 Big Picture & Weekly High Return Stock Forecasts - Newser
Why Astria Therapeutics Inc. stock remains a top recommendationMarket Sentiment Summary & Entry Point Confirmation Alerts - baoquankhu1.vn
When is the best time to exit Astria Therapeutics Inc.Earnings Recap Report & Low Risk Entry Point Tips - Newser
Is Astria Therapeutics Inc. stock poised for growthTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
How sentiment analysis helps forecast Astria Therapeutics Inc.Options Play & Weekly Return Optimization Plans - Newser
Astria Therapeutics Inc. stock prediction for this weekWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser
Key metrics from Astria Therapeutics Inc.’s quarterly dataRecession Risk & Risk Controlled Stock Alerts - Newser
Using flow based indicators on Astria Therapeutics Inc.Layoff News & Verified Short-Term Plans - Newser
What indicators show strength in Astria Therapeutics Inc.Gap Down & Real-Time Stock Entry Alerts - Newser
Has Astria Therapeutics Inc. formed a bullish divergenceJuly 2025 Macro Moves & Intraday High Probability Alerts - Newser
Long term hold vs stop loss in Astria Therapeutics Inc.Portfolio Risk Summary & Breakout Confirmation Alerts - Newser
What’s next for Astria Therapeutics Inc. stock priceMarket Growth Review & Free Reliable Trade Execution Plans - Newser
All You Need to Know About Astria Therapeutics (ATXS) Rating Upgrade to Buy - sharewise.com
Real time scanner hits for Astria Therapeutics Inc. explainedQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Visual trend scoring systems applied to Astria Therapeutics Inc.2025 Macro Impact & Weekly Chart Analysis and Guides - Newser
Is Astria Therapeutics Inc. stock reversal real or fakeQuarterly Trade Summary & Community Consensus Trade Signals - Newser
What MACD signals say about Astria Therapeutics Inc.2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Wall Street Analysts Believe Astria Therapeutics (ATXS) Could Rally 294.75%: Here's is How to Trade - MSN
What earnings revisions data tells us about Astria Therapeutics Inc.July 2025 Intraday Action & AI Powered Buy and Sell Recommendations - Newser
Is Astria Therapeutics Inc. a candidate for recovery playShort Setup & Capital Efficient Trade Techniques - Newser
Aug Gainers: Is Astria Therapeutics Inc. trading at a discountJuly 2025 Macro Moves & Technical Confirmation Alerts - Lancaster City Council
Can Astria Therapeutics Inc. stock outperform in a bear marketQuarterly Earnings Summary & Weekly Hot Stock Watchlists - Lancaster City Council
Published on: 2025-09-09 07:13:11 - Newser
key metrics from astria therapeutics inc.’s quarterly dataPortfolio Growth Summary & Daily Growth Stock Tips - Newser
103,517 Shares in Astria Therapeutics, Inc. $ATXS Acquired by Nuveen LLC - MarketBeat
Astria Therapeutics Inc Stock (ATXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):